SC83288 is a clinical development candidate for the treatment of severe malaria

por Stefano Pegoraro, Maëlle Duffey, Thomas D Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K Fehler, Leonardo Lucantoni, Vicky M Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J Vial, Stefan Strobl, Cecilia P Sanchez, Michael Lanzer
Publicado 2017

Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria

por Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez, Michael Lanzer
Publicado 2017

SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization

por Nkerorema Djodji Damas, Michela Marcatti, Christophe Côme, Lise Lotte Christensen, Morten Muhlig Nielsen, Roland Baumgartner, Helene Maria Gylling, Giulia Maglieri, Carsten Friis Rundsten, Stefan E. Seemann, Nicolas Rapin, Simon Thézenas, Søren Vang, Torben Ørntoft, Claus Lindbjerg Andersen, Jakob Skou Pedersen, Anders H. Lund
Publicado 2016